Applications of 16-Dehydropregnenolone Acetate in Industrial Manufacturing

As a producer specializing in steroid intermediates, we supply 16-Dehydropregnenolone Acetate to advanced industrial users requiring precise consistency for regulated synthesis processes. Below, we detail major application areas supported by our material, including integration methods, compliance frameworks, and typical formulation roles in downstream manufacturing.

1. Corticosteroid API Synthesis for Pharmaceutical Manufacturing

Pharmaceutical companies widely use this intermediate in multi-step synthesis of glucocorticoid drugs. Production lines typically incorporate it after pregnenolone acetate modifications, using controlled hydrogenation and selective oxidation. Our material supports consistent batch yields to enable precise control of targeted functional groups, reducing downstream impurities and facilitating multi-gram to commercial-scale active pharmaceutical ingredient (API) output. We provide material in compliance with stringent traceability standards and certificate-of-analysis batch support for regulated drug intermediates.

Industry compliance standards

• cGMP as defined by US FDA 21 CFR Parts 210/211
• ICH Q7 and Q11 guidance for pharmaceutical intermediates
• Chinese Pharmacopoeia ChP 2020 for steroidal intermediates
• EU EudraLex Volume 4 GMP

Typical usage ratio

• 100–120 kg raw material per 100 kg target corticosteroid API, adjusted for process efficiency, yield, and reaction pathway

Downstream process integration

• Introduced as a key substrate after pregnenolone acetate derivatization, before key oxidation and reduction steps, via sealed reactor charging, monitored by HPLC or TLC

Final product types

• Hydrocortisone (API)
• Prednisolone (API)
• Methylprednisolone (API)
• Dexamethasone (API)

2. Progestin Intermediate in Hormonal Drug Development

Steroid hormone manufacturers employ this intermediate for the synthesis of advanced progestational agents. The material enters as a backbone for C16-modified progestins, suited for transformation via acetylation, reduction, and cyclization reactions. Our manufacturing process ensures high purity and low residual solvents, fulfilling strict specification limits for injectable and oral finished dosage forms. Regular GMP audits and systematic impurity profiling support full regulatory traceability.

Industry compliance standards

• EU Directive 2001/83/EC for medicinal product intermediates
• US Pharmacopeia USP 44 for intermediates
• WHO GMP for steroid hormone production
• TGA Australian GMP Part II

Typical usage ratio

• 85–110 g per 100 g finished progestin API, with adjustments based on target yield and batch scale

Downstream process integration

• Added as a key starting material in intermediate progestin synthesis, typically following saponification or cleavage, prior to catalyst-mediated reduction

Final product types

• Medroxyprogesterone acetate (API)
• Norethindrone (API)
• Lynestrenol (API)
• Hydroxyprogesterone caproate (API)

3. Intermediate for Veterinary Steroid Hormone Formulation

Suppliers of veterinary pharmaceuticals process this material in the manufacture of steroidal hormone agents for livestock. Our intermediate assists in the synthesis of anabolic steroids and corticosteroids for veterinary use, undergoing protection and deacetylation reactions followed by side-chain extension. We guarantee production under veterinary GMP schemes and provide documentation for residue testing and cross-contamination control, critical for regulatory approval in animal health applications.

Industry compliance standards

• VICH GL22 (Veterinary Medicinal Product GMP)
• EU Regulation (EC) No 470/2009 for veterinary MRLs
• US FDA 21 CFR 500 (Veterinary Drugs)
• China GB/T 13086 for veterinary pharmaceuticals

Typical usage ratio

• 90–115 g per 100 g veterinary steroid API, controlled by final activity assay and formulation scale

Downstream process integration

• Charged after initial backbone synthesis, often post-hydrolysis, then utilized in C17 modification or lactone ring formation

Final product types

• Trenbolone acetate (API for veterinary implant)
• Boldenone undecylenate (API)
• Corticosteroid injectables (veterinary use)

4. Precursor for Steroidal Research Reagents and Analytical Standards

Producers of laboratory and diagnostic reagents use this material as a precursor for developing steroid-based analytical standards and isotopically labelled compounds. It is incorporated during chemical synthesis for stable-isotope labelling, reference calibrators, and as an internal standard for LC-MS/MS quantification. Our facility ensures analytical-grade production with complete documentation for trace impurities, supporting both GLP laboratory and metrology applications.

Industry compliance standards

• ISO 17034 (Reference Material Producers)
• OECD GLP for test item production
• USP Analytical Reference Standards guidelines

Typical usage ratio

• Varies from 10 mg to 10 g per batch, adjusted per final target analyte and synthesis pathway

Downstream process integration

• Used as early-stage precursor in the synthesis route for labelled derivatives, typically via selective acetylation and mass modification for isotopic incorporation

Final product types

• 13C or 2H-labelled steroidal analytical standards
• High-purity steroid reference solutions
• QC calibrators for pharmaceutical assay and diagnostic use